Siemens' molecular testing systems enable early detection of major infectious diseases; monitoring of treatment efficacy; and selection of targeted, individualized treatment options. The combination of infectious disease immunoassay and molecular testing offers a total solution for diagnosis and monitoring of HIV and hepatitis.
Product availability varies from country to country and is subject to local regulatory requirements. Please contact your local representative for availability.